Group K Diagnostics, Inc. — Form D
Group K Diagnostics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-31. The offering totals $1.0M, of which $655K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-07-31
- Form: D
- Accession: 0001015325-20-000022
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $655K
- Remaining: $345K
- Investors: 4
- Date of first sale: 2020-07-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372205
Issuer
- Name: Group K Diagnostics, Inc.
- CIK: 0001752046
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1015 Chestnut Street, PHILADELPHIA, PA, 19107
- Phone: 201-450-8785
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paul Farr | Director | Santa Monica, CA |
| Brianna Wronko | Director | PHILADELPHIA, PA |
| Brianna Wronko | Executive Officer | PHILADELPHIA, PA |
| Brianna Wronko | Promoter | PHILADELPHIA, PA |
| Joe Geromini | Executive Officer | Philadelphia, PA |
| Joe Geromini | Promoter | Philadelphia, PA |
Other filings by this issuer (3)
More